[Myocardial perfusion SPECT and isotopic ventriculography in obstructive and non-obstructive hypertrophic

G Romero-Farina1, J Candell-Riera, O Pereztol-Valdés

  • 1Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Insights

Myocardial perfusion SPECT and radionuclide ventriculography do not predict outcomes in hypertrophic cardiomyopathy (HC). However, non-reversible defects correlate with ECG changes and indicate potential progression to dilated cardiomyopathy.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HC) is a complex condition affecting the heart muscle.
  • Accurate prognostic tools are crucial for managing HC patients.

Purpose of the Study:

  • To assess the prognostic value of myocardial perfusion single-photon emission computed tomography (SPET) and radionuclide ventriculography in patients with HC.
  • To identify imaging markers associated with disease progression or adverse events.

Main Methods:

  • Exercise myocardial perfusion SPET with 99mTc-tetrofosmin and radionuclide ventriculography were performed in 101 HC patients.
  • Patients were followed for an average of 9.9 years, with a range of 1 to 28 years.

Main Results:

  • Thirty-six percent of patients showed perfusion defects (15% non-reversible, 21% reversible).
  • Non-reversible defects were more common in non-obstructive HC and associated with ECG abnormalities (pathologic Q waves), higher ventricular volumes, lower ejection fraction, and slower emptying velocity.
  • No imaging variable predicted mortality, pacemaker implantation, or myectomy; however, syncope was linked to higher ejection fraction.

Conclusions:

  • Myocardial perfusion SPET and radionuclide ventriculography lack prognostic value in HC.
  • Non-reversible perfusion defects may indicate progression towards a dilated form of HC.
  • Syncope in HC patients is associated with higher ejection fraction, but this finding lacks clear prognostic implication from the imaging modalities used.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...